Skip to main content
. 2019 Aug 22;13:2941–2955. doi: 10.2147/DDDT.S205000

Table 7.

Summary of adverse events in the renal impairment study

Category, n (%) Severe renal impairment (N=10) Healthy control (N=10) All subjects (N=20)
Any AE 7 (70.0) 5 (50.0) 12 (60.0)
Serious AE 0 0 0
AE leading to discontinuation 0 0 0
AE by highest severity
 Mild 5 (50.0) 2 (20.0) 7 (35.0)
 Moderate 2 (20.0) 1 (10.0) 3 (15.0)
 Severe 0 2 (20.0) 2 (10.0)
AEs in ≥2 subjects in any cohort
 Somnolence 2 (20.0) 3 (30.0) 5 (25.0)
 Abdominal pain 2 (20.0) 1 (10.0) 3 (15.0)
 Dizziness 2 (20.0) 1 (10.0) 3 (15.0)
 Nausea 2 (20.0) 1 (10.0) 3 (15.0)
 Lethargy 2 (20.0) 0 2 (10.0)

Abbreviation: AE, adverse event.